Neurodevelopmental Aspects of RASopathies

Area of Science:

• Genetics and Developmental Biology
• Molecular Biology
• Neuroscience

Background:

• RAS gene mutations are prevalent in human cancers.
• Gain-of-function mutations in the RAS/mitogen-activated protein kinase (RAS/MAPK) pathway cause RASopathies, affecting approximately 1 in 1,000 newborns.
• The RAS-MAPK pathway is crucial for cell proliferation, differentiation, and migration during development.

Purpose of the Study:

• To review the role of RAS-MAPK pathway components in neurodevelopmental processes.
• To discuss the pathogenesis of RASopathies, focusing on neurological defects.

Main Methods:

• This is a review article, synthesizing existing research.
• Literature search on RAS gene mutations, RAS/MAPK pathway, RASopathies, and neurodevelopmental disorders.

Main Results:

• RASopathies are associated with significant central nervous system abnormalities.
• Common neurological defects include developmental delay, macrocephaly, seizures, neurocognitive deficits, and structural malformations.
• Dysregulation of molecular and cellular processes within the RAS-MAPK pathway contributes to early neurodevelopmental issues.

Conclusions:

• The RAS-MAPK pathway is fundamentally involved in normal neurodevelopment.
• Understanding the implications of RAS-MAPK pathway dysregulation is key to addressing the pathogenesis of RASopathies.
• Further research into these molecular mechanisms can inform therapeutic strategies for neurodevelopmental disorders.